Empresa Eléctrica Pehuenche S.A. (SNSE:PEHUENCHE)

Akoya Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	151.28	162.83	168.42	220.01	123.2	122.59
Depreciation & Amortization	7.14	6.84	7.74	8.87	8.77	10.49
Other Operating Activities	7.8	-9.82	-26.1	4.89	-17.07	3.89
Operating Cash Flow	166.22	159.86	150.07	233.77	114.9	136.97
Operating Cash Flow Growth	3.68%	6.52%	-35.81%	103.45%	-16.11%	21.87%
Capital Expenditures	-3.56	-4.16	-0.8	-6	-0.7	-0.47
Sale (Purchase) of Intangibles	-0.09	-0.08	-	-	-	-0.49
Other Investing Activities	8.73	-0.59	68.54	-81.21	-2.43	-18.64
Investing Cash Flow	5.08	-4.84	67.73	-87.21	-3.14	-19.6
Short-Term Debt Issued	-	-	-	-	-	46.91
Total Debt Issued	-	-	-	-	-	46.91
Short-Term Debt Repaid	-	-	-	-	-	-46.91
Total Debt Repaid	-	-	-	-	-	-46.91
Common Dividends Paid	-171.03	-154.96	-218.02	-146.88	-111.72	-117.35
Other Financing Activities	-	-	-	-	-	-0.01
Financing Cash Flow	-171.03	-154.96	-218.02	-146.88	-111.72	-117.36
Foreign Exchange Rate Adjustments	-0.32	-0.18	0.27	0.37	-	-
Net Cash Flow	-0.05	-0.12	0.05	0.06	0.04	0.02
Free Cash Flow	162.66	155.69	149.26	227.77	114.2	136.5
Free Cash Flow Growth	2.99%	4.31%	-34.47%	99.45%	-16.34%	22.26%
Free Cash Flow Margin	68.68%	62.10%	60.11%	71.03%	46.74%	59.66%
Free Cash Flow Per Share	0.27	0.25	0.24	0.37	0.19	0.22
Cash Interest Paid	-	-	-	-	-	0.01
Cash Income Tax Paid	60.25	66.61	78.05	55.52	61.83	38.36
Levered Free Cash Flow	103.85	138.87	163.34	149.84	99.02	106.25
Unlevered Free Cash Flow	103.85	138.92	163.46	149.88	99.02	106.26

Source: S&P Global Market Intelligence. Utility template. Financial Sources.